Incidence and Risk of Endocrine and Metabolic Abnormalities Linked to PARP Inhibitors in Solid Tumors: a Meta-Analysis

Shunlian Fu, Pingjin Zou, Zengyi Fang, Xinxiang Zhou,Junyang Chen, Cuicui Gong, Li Quan,Bing Lin,Qiu Chen,Jinyi Lang, Meihua Chen

BMC Cancer（2025）

Cited 0|Views3

Key words

PARP inhibitors,Endocrine and metabolic abnormalities,Meta-analysis

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined